Ticker

Quarterly revenue for Q2 2026 was $734,028, representing a 43% year-over-year growth. Loss per share for Q2, 2026: ($0. 07) per share. Announced further signed in-network contracts and credentialing with major U. S.

Agreement provides Rocket Doctor access across five network channels, including commercial healthcare, Medicare Advantage, workers' compensation and auto medical. National network serves more than 700 health plans, over 100,000 employers and approximately 60 million consumers, creating a broad pathway for eligible patients to access physician-led care.

Rocket Doctor Inc. has been selected as one of Canada's Top 100 AI and Tech Startups, recognizing the Company's leadership in applying artificial intelligence to improve healthcare access and patient outcomes. Selected from more than 330 applicants, Rocket Doctor AI will showcase its AI-powered healthcare platform at ALL IN 2026, Canada's largest event dedicated to artificial intelligence and advanced technologies.

Rocket Doctor signs its first value-based primary care agreement, enabling physicians to manage assigned patient panels under a recurring per-member-per-month care model. Rocket Doctor will add hundreds of patients to primary care provider panels, marking an important milestone in Rocket Doctor's U.